S
SciBac develops biotherapeutics that target antibiotic-resistant infections by utilizing advanced microbial engineering techniques. The company aims to provide effective treatment options for patients suffering from diseases caused by antibiotic-resistant bacteria.
Updated 20 months ago
Funding
$286.5K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
NIFunding rounds are not available yet.
Founders
Product
Features
- SciBac develops biotherapeutics that target antibiotic-resistant infections by utilizing advanced microbial engineering techniques. The company aims to provide effective treatment options for patients suffering from diseases caused by antibiotic-resistant bacteria.